SCHEMBL17640604

SCHEMBL17640604

c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2nc(-c3ccc(N4c5ccccc5Oc5ccccc54)c4ccccc34)no2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.40
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ NPC1 O15118 8/20 0.37
▸ SMN1; SMN2 Q16637 8/20 0.37
▸ RAB9A P51151 7/20 0.37
▸ HSD17B10 Q99714 5/20 0.37
▸ NR1H4 Q96RI1 4/20 0.37
▸ NFKB1 P19838 4/20 0.37
▸ NFKB2 Q00653 4/20 0.37
▸ RELA Q04206 4/20 0.37
▸ MAPT P10636 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PKM P14618 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ S1PR3 Q99500 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640527 0.85 NR1H4 (0.53) S1PR1BCHEACHENPC1SMN1; SMN2
SCHEMBL17640607 0.83 NR1H4 (0.51) S1PR1NPC1SMN1; SMN2RAB9AHSD17B10
SCHEMBL17640544 0.82 NR1H4 (0.58) S1PR1NPC1SMN1; SMN2RAB9AHSD17B10
SCHEMBL17640537 0.82 NR1H4 (0.58) S1PR1NPC1SMN1; SMN2RAB9AHSD17B10
SCHEMBL17640629 0.79 CYP19A1 (0.33) MAPT
SCHEMBL17640428 0.77 KDM4A (0.38) SMN1; SMN2
SCHEMBL17640609 0.77 NR1H4 (0.44) S1PR1NPC1SMN1; SMN2RAB9AHSD17B10
SCHEMBL17640623 0.76 NPC1 (0.44) S1PR1BCHEACHENPC1SMN1; SMN2
SCHEMBL19037648 0.76 P2RX4 (0.36) SMN1; SMN2HSD17B10NFKB1NFKB2RELA
SCHEMBL17640606 0.73 NPC1 (0.43) S1PR1NPC1SMN1; SMN2RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 S1PR1 4188/4885BCHE 4566/4885ACHE 3239/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 S1PR1 4188/4885BCHE 4566/4885ACHE 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback